Geron Corporation (GERN)
NASDAQ: GERN · Real-Time Price · USD
1.170
-0.040 (-3.31%)
At close: Jun 2, 2026, 4:00 PM EDT
1.220
+0.050 (4.27%)
Pre-market: Jun 3, 2026, 4:46 AM EDT

Geron Revenue

Geron had revenue of $51.84M in the quarter ending March 31, 2026, with 30.89% growth. This brings the company's revenue in the last twelve months to $196.12M, up 68.64% year-over-year. In the year 2025, Geron had annual revenue of $183.88M with 138.83% growth.

Revenue (ttm)
$196.12M
Revenue Growth
+68.64%
P/S Ratio
3.83
Revenue / Employee
$760,136
Employees
258
Market Cap
750.58M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025183.88M106.89M138.83%
Dec 31, 202476.99M76.76M32,386.92%
Dec 31, 2023237.00K-359.00K-60.23%
Dec 31, 2022596.00K-797.00K-57.21%
Dec 31, 20211.39M1.14M450.59%
Dec 31, 2020253.00K-207.00K-45.00%
Dec 31, 2019460.00K-606.00K-56.85%
Dec 31, 20181.07M1,000.000.09%
Dec 31, 20171.07M-5.10M-82.72%
Dec 31, 20166.16M-30.21M-83.06%
Dec 31, 201536.37M35.22M3,054.47%
Dec 31, 20141.15M-130.00K-10.13%
Dec 31, 20131.28M-1.43M-52.64%
Dec 31, 20122.71M271.00K11.12%
Dec 31, 20112.44M-1.13M-31.57%
Dec 31, 20103.56M1.84M106.43%
Dec 31, 20091.73M-1.08M-38.42%
Dec 31, 20082.80M-4.82M-63.22%
Dec 31, 20077.62M4.35M132.59%
Dec 31, 20063.28M-2.88M-46.78%
Dec 31, 20056.16M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Kura Oncology71.64M
CytomX Therapeutics35.54M
Evommune10.00M
Omeros9.89M
Odyssey Therapeutics2.98M
Allogene Therapeutics22.00K
Revenue Rankings